Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does proteasome [corrected] inhibition decrease or accelerate toxin-induced dopaminergic neurodegeneration?

Rieko Setsuie1, Tomohiro Kabuta, Keiji Wada

  • 1Department of Degenerative Neurological Diseases, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo.

Journal of Pharmacological Sciences
|March 15, 2005
PubMed
Summary

Proteasome inhibitors protect against Parkinson's disease (PD) by preventing dopaminergic cell death in a rat model. This unexpected finding suggests a complex role for the ubiquitin-proteasome system in PD pathogenesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of ESCRT-III activates alternative pathways for protein degradation and secretion.

Neurochemistry international·2026
Same author

Degradation of alpha-synuclein/SNCA mRNA by RNautophagy.

Neurochemistry international·2026
Same author

Association Between Oral Diadochokinesis, Grade and Sex in Japanese Elementary School Children: A Cross-Sectional Analysis From the Kuroishi Oral Health Study.

International journal of paediatric dentistry·2025
Same author

Microautophagy mediated by lysosomal membrane proteins: insights from LAMP2B-dependent microlipophagy.

Autophagy·2025
Same author

Vertebral changes evaluated by hounsfield units after spinal fusion surgery with concomitant anabolic therapy.

Archives of osteoporosis·2025
Same author

ERBB4 colocalizes with phosphorylated tau aggregates in multiple tauopathies.

Neurochemistry international·2025

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Parkinson's disease (PD) involves dopaminergic (DA) cell death and Lewy bodies (LB) composed of alpha-synuclein (alpha-syn) and ubiquitin (Ub).
  • The exact relationship between LB formation and DA cell loss in PD pathogenesis remains unclear.
  • Previous research suggested a link between impaired ubiquitin-proteasome system (UPS) function and DA cell death.

Purpose of the Study:

  • To investigate the effect of proteasome inhibitors (PSI) on dopaminergic cell death in a rat model of Parkinson's disease.
  • To explore the role of alpha-synuclein and ubiquitin accumulation in response to proteasome inhibition.
  • To clarify the complex relationship between the ubiquitin-proteasome system and Parkinson's disease pathogenesis.

Main Methods:

Related Experiment Videos

  • Utilized a rat model of Parkinson's disease induced by 6-hydroxyl dopamine (6-OHDA).
  • Administered proteasome inhibitors (lactacystin or MG-132) concurrently with 6-OHDA.
  • Assessed nigral degeneration and apomorphine-induced rotational asymmetry.
  • Examined the appearance of alpha-synuclein and ubiquitin-positive inclusions in the substantia nigra.

    • Main Results:

    • Co-administration of proteasome inhibitors significantly prevented nigral degeneration in the rat PD model.
    • PSI treatment reduced apomorphine-induced rotational asymmetry, a behavioral marker of PD.
    • Increased alpha-synuclein and ubiquitin-positive inclusions were observed in the substantia nigra following PSI treatment.

    Conclusions:

    • Accelerated formation of alpha-synuclein and ubiquitin inclusions, induced by proteasome inhibition, appears to protect against dopaminergic cell death in this model.
    • The findings suggest that the ubiquitin-proteasome system's role in Parkinson's disease pathogenesis may be more intricate than previously understood.
    • This study challenges the conventional view by demonstrating a protective effect of proteasome inhibition in a PD model.